Dr. Britton is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1542 Medical Park Cir
Tupelo, MS 38801Phone+1 662-844-4711
Summary
- Dr. Marcus Britton is a nephrologist based in Tupelo, MS, with specialized training in nephrology obtained through his fellowship at the University of Texas Health Science Center at Houston from 2007 to 2009. He completed his medical degree at the University of Mississippi School of Medicine in 2004, followed by a residency in internal medicine at the University of Mississippi Medical Center from 2004 to 2007. Dr. Britton has experience in managing conditions such as acute renal failure, chronic renal failure, and diabetes mellitus. His published work includes notable studies on roxadustat and kidney pathology in COVID-19, with his research being cited 99 times. He received the Meaningful Use Stage 1 Certification from the Centers for Medicare & Medicaid Services in 2011.
Education & Training
- University of Texas Health Science Center at HoustonFellowship, Nephrology, 2007 - 2009
- University of Mississippi Medical CenterResidency, Internal Medicine, 2004 - 2007
- University of Mississippi School of MedicineClass of 2004
Certifications & Licensure
- TX State Medical License 2007 - 2026
- AL State Medical License 2010 - 2025
- MS State Medical License 2005 - 2025
- TN State Medical License 2018 - 2025
- American Board of Internal Medicine Nephrology
- National Board of Physicians and Surgeons Internal Medicine
- National Board of Physicians and Surgeons Nephrology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Publications & Presentations
PubMed
- A phase 3b, multicenter, open-label, single-arm study of roxadustat within a US dialysis organization: The DENALI study.John Larkin, Jeffrey Hymes, Marcus L Britton, Yemmie Oluwatosin, Jacqueline Nolen
Hemodialysis International. International Symposium on Home Hemodialysis. 2024-01-01 - 98 citationsA multi-center retrospective cohort study defines the spectrum of kidney pathology in Coronavirus 2019 Disease (COVID-19).Rebecca M. May, Clarissa A. Cassol, Andrew Hannoudi, Christopher P. Larsen, Edgar V. Lerma
Kidney International. 2021-08-03
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: